"Chinese and Western Complementarity, Integration and Innovation" - The 19th National Academic Conference on New Progress in Comprehensive Tumor Therapy Held Successfully

2023-03-25

October 28-30, 2021, co-hosted by the World Federation of Chinese Medicine Societies, China National Medical Association, Guangdong Provincial Association of Traditional Chinese Medicine, Guangdong Provincial Basic Medicine Association, and Guangzhou University of Traditional Chinese Medicine, World Federation of Chinese Medicine Societies Cancer Palliative The "Nineteenth National Cancer Academic Conference on New Progress in Comprehensive Therapy and the 7th Academic Annual Meeting of the Cancer Palliative Care Research Committee of the World Federation of Chinese Medicine Societies, the 7th Academic Annual Meeting of the Tumor Branch of the Chinese Association of Ethnic Medicine, the Summit Forum on Integrated Traditional Chinese and Western Medicine for Tumors, and the Singapore Overseas Summit The Forum and National Continuing Education Project-Tumor Comprehensive Therapy New Progress Study Class was held in Guangzhou, China. Co-organized by the Cancer Rehabilitation Professional Committee of the Society of Integrative Western Medicine, the Cancer Psychology Professional Committee of the Guangdong Association of Integrative Traditional Chinese and Western Medicine, and the Cancer Chemotherapy Professional Committee of the Guangdong Provincial Association of Integrative Traditional and Western Medicine.

与此原文有关的更多信息要查看其他翻译信息,您必须输入相应原文

发送反馈

侧边栏


The theme of this conference is "Complementarity between China and the West, Integration and Innovation". According to the characteristics of traditional Chinese medicine and integrated traditional Chinese and Western medicine in cancer prevention and treatment, scientific innovation, display the latest research results of integrated traditional Chinese and western medicine on tumors, gather multidisciplinary resources and advantages, explore the establishment of a more complete comprehensive tumor treatment system; and conduct extensive research on the adverse reactions of traditional Chinese medicine treatment of tumors In-depth research, formulation and formation of TCM consensus and standards for adverse reactions of tumor treatment. The conference adopts a combination of online and offline methods, bringing together famous tumor experts at home and abroad to conduct academic exchanges in various forms such as invited reports, special lectures, satellite meetings, etc., to learn from each other and improve together, and strive to comprehensively and accurately Demonstrate the role of traditional Chinese medicine in the diagnosis and treatment of tumors.

Professor Lin Lizhu, vice president of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, doctor of medicine, chief physician, national key clinical specialty, and academic leader of the State Administration of Traditional Chinese Medicine key specialty, is the executive chairman of this conference.

The conference was chaired by Professor Zhou Daihan, a master of traditional Chinese medicine and chief professor of Guangzhou University of Traditional Chinese Medicine. Medical work scholars set a model for learning and point out the way forward.


Mengyang Pharmaceutical was also honored to bring Shengbai oral liquid (mixture), an exclusive product of Medicare, to participate in this academic feast. During the meeting, it made a product demonstration, which attracted the attention of many experts. "Don't forget the original intention, keep the mission in mind", as a professional manufacturer specializing in solving the toxic and side effects of tumor treatment, Mengyang Pharmaceutical will continue to uphold the corporate mission of improving the quality of life of cancer patients, continue to explore and innovate, and strive to use the classic prescriptions and Active ingredients derived from natural medicines are developed into new medicines, traditional Chinese medicine and Western medicine are integrated and innovated, based on benevolence, giving full play to the advantages of traditional Chinese medicine, and continuously contributing corporate power to the cause of cancer prevention and treatment!




Hot news

Service hotline

0724-8886111

Address:3 Fuyao Yi Lu, Doudao District, Jingmen City, Hubei Province, China
Transmissionh:0724-8686500
Email:hbmy_monyan@163.com

COPYRIGHT© 2022 Hubei Mengyang Pharmaceutical Co., LTD. All Rights Reserved E ICP 11014915; Internet Drug Information Service Certificate No. : (E) - Non-business -2016-0032

Technical Support: SUMA